Aneurysm Thoracic

2

Review clinical trials related to Aneurysm Thoracic. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance

An observational, prospective multi-regional post-market registry collecting mid- and long-term data to assess outcomes through ten years of follow-up for subjects treated with GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System as a part of routine clinical practice. This post-market registry for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System (CTAG w/AC) is intended to demonstrate that thoracic endovascular aortic repair (TEVAR) for lesions of the descending thoracic aorta continues to be a suitable treatment option for appropriately selected patients.

Participants needed: 1,500
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: W.L.Gore & AssociatesUpdated: Jun 23, 2026Locations: 36Duration: 10 Years
Eligibility criteria

Patient or legally authorized representative (LAR) provides written authorizatio... [+3]

Patient who is, at the time of consent, unlikely to be available for standard of... [+3]

Status: Recruiting

TBE Zone 2 PMS in Japan

The goal of this surveillance is to confirm the TBE device's safety and efficacy in patients treated with proximal landing in Zone 2 in the post-marketing period.

Participants needed: 200
Trial details
Biological sex: AllType: ObservationalSponsor: W.L.Gore & AssociatesUpdated: Feb 5, 2026Locations: 1Duration: 60 Months
Eligibility criteria

Those who are suitable for use of TBE according to the Japan package insert. [+3]

N/A